Breast Carcinoma In Situ — Trials

Breast Carcinoma In Situ — Trials · CancerIndex

Clinical trials

Registered studies

194 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 58
Recruiting: 30
Ph III recruiting: 2
Growth YoY: —
Industry share: 3%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (30)

clinicaltrialsPublishedShowing 1–8 of 8 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03868475	Comparing Vacuum-Assisted Percutaneous Excision to Open Surgical Excision for Borderline or High-Risk Breast Lesions(VAPEX)	withdrawn	N/A	0	London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sOTHER	0	Mar 9, 2026	clinicaltrials
NCT05032079	Subzero and Scorpion Trial	withdrawn	N/A	0	Larkin Community HospitalOTHER	1	Oct 16, 2023